Molecular characterization of Helicobacter pylori clinical isolates from Eastern Saudi Arabia

References

1. 1.↵
   1. Piscione M,
   2. Mazzone M,
   3. Di Marcantonio MC,
   4. Muraro R,
   5. Mincione G.

   Eradication of Helicobacter pylori and gastric cancer: a controversial relationship. Front Microbiol 2021; 12: 630852.

   OpenUrlGoogle Scholar
2. 2.↵
   1. Ghotaslou R,
   2. Leylabadlo HE,
   3. Asl YM.

   Prevalence of antibiotic resistance in Helicobacter pylori: a recent literature review. World J Methodol 2015; 5: 164-174.

   OpenUrlCrossRefPubMedGoogle Scholar
3. 3.↵
   1. Savoldi A,
   2. Carrara E,
   3. Graham DY,
   4. Conti M,
   5. Tacconelli E.

   Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology 2018; 155: 1372-1382.

   OpenUrlCrossRefPubMedGoogle Scholar
4. 4.↵
   1. Liu Y,
   2. Wang S,
   3. Yang F,
   4. Chi W,
   5. Ding L,
   6. Liu T, et al.

   Antimicrobial resistance patterns and genetic elements associated with the antibiotic resistance of Helicobacter pylori strains from Shanghai. Gut Pathog 2022; 14: 14.

   OpenUrlGoogle Scholar
5. 5.↵
   1. Hirata K,
   2. Suzuki H,
   3. Nishizawa T,
   4. Tsugawa H,
   5. Muraoka H,
   6. Saito Y, et al.

   Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. J Gastroenterol Hepatol 2010; 25: S75-S79.

   OpenUrlCrossRefPubMedGoogle Scholar
6. 6.↵
   1. Binh TT,
   2. Shiota S,
   3. Suzuki R,
   4. Matsuda M,
   5. Trang TT,
   6. Kwon DH, et al.

   Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing. J Antimicrob Chemother 2014; 69: 1796-1803.

   OpenUrlCrossRefPubMedGoogle Scholar
7. 7.↵
   1. Bińkowska A,
   2. Biernat MM,
   3. Łaczmański Ł,
   4. Gościniak G.

   Molecular patterns of resistance among Helicobacter pylori strains in South-Western Poland. Front Microbiol 2018; 9: 3154.

   OpenUrlGoogle Scholar
8. 8.↵
   1. Seck A,
   2. Burucoa C,
   3. Dia D,
   4. Mbengue M,
   5. Onambele M,
   6. Raymond J, et al.

   Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients. Ann Clin Microbiol Antimicrob 2013; 12: 3.

   OpenUrlGoogle Scholar
9. 9.↵
   1. Hanafi A,
   2. Lee WC,
   3. Loke MF,
   4. Teh X,
   5. Shaari A,
   6. Dinarvand M, et al.

   Molecular and proteomic analysis of levofloxacin and metronidazole resistant Helicobacter pylori. Front Microbiol 2016; 7: 2015.

   OpenUrlCrossRefGoogle Scholar
10. 10.↵
    1. Megraud F,
    2. Coenen S,
    3. Versporten A,
    4. Kist M,
    5. Lopez-Brea M,
    6. Hirschl AM, et al.

    Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34-42.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
11. 11.↵
    1. Akeel M,
    2. Shehata A,
    3. Elhafey A,
    4. Elmakki E,
    5. Aboshouk T,
    6. Ageely H, et al.

    Helicobacter pylori vacA, cagA and iceA genotypes in dyspeptic patients from southwestern region, Saudi Arabia: distribution and association with clinical outcomes and histopathological changes. BMC Gastroenterol 2019; 19: 16.

    OpenUrlGoogle Scholar
12. 12.↵
    1. Bridge DR,
    2. Merrell DS.

    Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease. Gut Microbes 2013; 4: 101-117.

    OpenUrlCrossRefGoogle Scholar
13. 13.↵
    1. Alghamdi TS,
    2. Ansari T,
    3. Bashir AA,
    4. Batais MA,
    5. Aldhahi MF,
    6. Alanazi MA.

    Helicobacter Pylori infection among dyspepsia patients in suburbs of Riyadh, Saudi Arabia. J Pak Med Assoc 2020; 70: 2174-2177.

    OpenUrlGoogle Scholar
14. 14.
    1. Momenah AM,
    2. Tayeb MT.

    Helicobacter pylori cagA and iceA genotypes status and risk of peptic ulcer in Saudi patients. Saudi Med J 2007; 28: 382-385.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
15. 15.
    1. Elsawaf ZM,
    2. Albasri AM,
    3. Hussainy AS,
    4. Alhujaily AS.

    Histopathological pattern of benign endoscopic gastric biopsies in Western Saudi Arabia: a review of 1236 cases. J Pak Med Assoc 2017; 67: 252-255.

    OpenUrlGoogle Scholar
16. 16.↵
    1. Akeel M,
    2. Elmakki E,
    3. Shehata A,
    4. Elhafey A,
    5. Aboshouk T,
    6. Ageely H, et al.

    Prevalence and factors associated with H. pylori infection in Saudi patients with dyspepsia. Electron Physician 2018; 10: 7279-7286.

    OpenUrlGoogle Scholar
17. 17.↵
    1. Al-Hussaini AA,
    2. Al Jurayyan AN,
    3. Bashir SM,
    4. Alshahrani D.

    Where are we today with Helicobacter pylori infection among healthy children in Saudi Arabia? Saudi J Gastroenterol 2019; 25: 309-318.

    OpenUrlGoogle Scholar
18. 18.↵
    1. Falsafi T,
    2. Favaedi R,
    3. Mahjoub F,
    4. Najafi M.

    Application of stool-PCR test for diagnosis of Helicobacter pylori infection in children. World J Gastroenterol 2009; 15: 484-488.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
19. 19.↵
    1. Park CY,
    2. Kwak M,
    3. Gutierrez O,
    4. Graham DY,
    5. Yamaoka Y.

    Comparison of genotyping Helicobacter pylori directly from biopsy specimens and genotyping from bacterial cultures. J Clin Microbiol 2003; 41: 3336-3338.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
20. 20.↵
    1. Chen J,
    2. Ye L,
    3. Jin L,
    4. Xu X,
    5. Xu P,
    6. Wang X, et al.

    Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23s rRNA gene. Ann Clin Microbiol Antimicrob 2018; 17: 10.

    OpenUrlCrossRefGoogle Scholar
21. 21.↵
    1. Saber T,
    2. Ghonaim MM,
    3. Yousef AR,
    4. Khalifa A,
    5. Al Qurashi H,
    6. Shaqhan M, et al.

    Association of Helicobacter pylori cagA gene with gastric cancer and peptic ulcer in Saudi patients. J Microbiol Biotechnol 2015; 25: 1146-1153.

    OpenUrlGoogle Scholar
22. 22.↵
    1. Marie MA.

    Relationship between Helicobacter pylori virulence genes and clinical outcomes in Saudi patients. J Korean Med Sci 2012; 27: 190-193.

    OpenUrlPubMedGoogle Scholar
23. 23.↵
    1. Backert S,
    2. Tegtmeyer N,
    3. Fischer W. Composition

    , structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system. Future Microbiol 2015; 10: 955-965.

    OpenUrlCrossRefGoogle Scholar
24. 24.↵
    1. Kontizas E,
    2. Tastsoglou S,
    3. Karamitros T,
    4. Karayiannis Y,
    5. Kollia P,
    6. Hatzigeorgiou AG, et al.

    Impact of Helicobacter pylori infection and its major virulence factor CagA on DNA damage repair. Microorganisms 2020; 8: 2007.

    OpenUrlGoogle Scholar
25. 25.↵
    1. Horiuchi S,
    2. Nakano R,
    3. Nakano A,
    4. Hishiya N,
    5. Uno K,
    6. Suzuki Y, et al.

    Prevalence of Helicobacter pylori among residents and their environments in the Nara prefecture, Japan. J Infect Public Health 2021; 14: 271-275.

    OpenUrlGoogle Scholar
26. 26.↵
    1. Palframan SL,
    2. Kwok T,
    3. Gabriel K.

    Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front Cell Infect Microbiol 2012; 2: 92.

    OpenUrlGoogle Scholar
27. 27.↵
    1. Figueroa G,
    2. Troncoso M,
    3. Toledo MS,
    4. Faúndez G,
    5. Acuña R.

    Prevalence of serum antibodies to Helicobacter pylori VacA and CagA and gastric diseases in Chile. J Med Microbiol 2002; 51: 300-304.

    OpenUrlPubMedGoogle Scholar
28. 28.↵
    1. Monroy FP,
    2. Brown HE,
    3. Sanderson PR,
    4. Jarrin G,
    5. Mbegbu M,
    6. Kyman S, et al.

    Helicobacter pylori in Native Americans in Northern Arizona. Diseases 2022; 10: 19.

    OpenUrlGoogle Scholar
29. 29.↵
    1. McClain MS,
    2. Beckett AC,
    3. Cover TL.

    Helicobacter pylori vacuolating toxin and gastric cancer. Toxins (Basel) 2017; 9: 316.

    OpenUrlGoogle Scholar
30. 30.↵
    1. Yamaoka Y,
    2. Kodama T,
    3. Kita M,
    4. Imanishi J,
    5. Kashima K,
    6. Graham DY.

    Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 1998; 3: 241-253.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
31. 31.↵
    1. Al-Khattaf AS.

    Helicobacter pylori virulence markers in gastroduodenal disorders. Detection of cytotoxin-associated gene A and vacuolating cytotoxin-associated gene A genes in Saudi patients. Saudi Med J 2012; 33: 716-721.

    OpenUrlPubMedGoogle Scholar
32. 32.↵
    1. Momenah AM,
    2. Tayeb MT.

    Relationship between Helicobacter pylori vacA genotypes status and risk of peptic ulcer in Saudi patients. Saudi Med J 2006; 27: 804-807.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
33. 33.↵
    1. Bibi F,
    2. Alvi SA,
    3. Sawan SA,
    4. Yasir M,
    5. Sawan A,
    6. Jiman-Fatani AA, et al.

    Detection and genotyping of Helicobacter pylori among gastric ulcer and cancer patients from Saudi Arabia. Pak J Med Sci 2017; 33: 320-324.

    OpenUrlGoogle Scholar
34. 34.↵
    1. Kamboj AK,
    2. Cotter TG,
    3. Oxentenko AS.

    Helicobacter pylori: the past, present, and future in management. Mayo Clin Proc 2017; 92: 599-604.

    OpenUrlCrossRefGoogle Scholar
35. 35.↵
    1. Eed EM,
    2. Hawash YA,
    3. Khalifa AS,
    4. Alsharif KF,
    5. Alghamdi SA,
    6. Saber T, et al.

    Molecular diagnosis of Helicobacter pylori antibiotic resistance in the Taif region, Saudi Arabia. Microbiol Immunol 2019; 63: 199-205.

    OpenUrlGoogle Scholar
36. 36.↵
    1. Phan TN,
    2. Santona A,
    3. Tran VH,
    4. Tran TN,
    5. Le VA,
    6. Cappuccinelli P, et al.

    High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam. Int J Antimicrob Agents 2015; 45: 244-248.

    OpenUrlGoogle Scholar
37. 37.↵
    1. Waskito LA,
    2. Salama NR,
    3. Yamaoka Y.

    Pathogenesis of Helicobacter pylori infection. Helicobacter 2018; 23: e12516.

    OpenUrlGoogle Scholar
38. 38.↵
    1. Domanovich-Asor T,
    2. Motro Y,
    3. Khalfin B,
    4. Craddock HA,
    5. Peretz A,
    6. Moran-Gilad J.

    Genomic analysis of antimicrobial resistance genotype-to-phenotype agreement in Helicobacter pylori. Microorganisms 2020; 9: 2.

    OpenUrlGoogle Scholar
39. 39.↵
    1. Hussein RA,
    2. Al-Ouqaili MTS,
    3. Majeed YH.

    Detection of clarithromycin resistance and 23srRNA point mutations in clinical isolates of Helicobacter pylori isolates: phenotypic and molecular methods. Saudi J Biol Sci 2022; 29: 513-520.

    OpenUrlGoogle Scholar
40. 40.↵
    1. Zhang Y,
    2. Wen Y,
    3. Xiao Q,
    4. Zheng W,
    5. Long G,
    6. Chen B, et al.

    Mutations in the antibiotic target genes related to clarithromycin, metronidazole and levofloxacin resistance in Helicobacter pylori strains from children in China. Infect Drug Resist 2020; 13: 311-322.

    OpenUrlGoogle Scholar